Financial Statements
22. Inventories
Inventories comprised:
| Dec. 31, 2006 | Dec. 31, 2007 | |
| € million | ||
| Raw materials and supplies | 1,004 | 1,012 |
| Work in process, finished goods and goods purchased for resale | 5,145 | 5,197 |
| Advance payments | 4 | 8 |
| Total | 6,153 | 6,217 |
Of the inventories totaling €6,217 million as of December 31, 2007 (2006: €6,153 million), €691 million (2006: €910 million) were carried at fair value less costs to sell.
The changes in the inventory reserve, which are reflected in the cost of goods sold, were as follows:
The changes in the inventory reserve, which are reflected in the cost of goods sold, were as follows:
| 2006 | 2007 | |
| € million | ||
| January 1 | (340) | (311) |
| Changes in the scope of consolidation | - | (3) |
| Additions expensed | (180) | (149) |
| Deductions due to reversal or utilization | 151 | 130 |
| Reclassifications to current assets | 46 | - |
| Exchange differences | 12 | 15 |
| December 31 | (311) | (318) |



Chairman’s Letter
Notes
Bayer Links
Investor Relations
back to overview
Bookmark this page
E-mail this page
Advanced Search

